Instrument Business Outlook Volume 32 - Issue 12

3 Oct 2023

Categories:

Instrument Business Outlook

Table of Contents

Life Science Tool Companies Continue to Reduce Costs and Focus on Profitability
- Expense Reduction
- Investments
- M&A
- New Funding
Executive Briefing
- Abcam Shareholder Urges “No” Vote on Danaher Offer
- Court Ruling Leads to New Injunction for NanoString Instrument
- Danaher Completes Veralto Separation
- Battery Ventures Acquires Three Companies
- Biosynth Further Invests in Peptides
- Repligen Buys Bioprocess Single-Use Mixing Company
- TECNILABO Formed
IBO Stock Indexes Continue Decline in September
- Laboratory Instruments and Products Stock Index
- Diversified Instrumentation Stock Index
- International Stocks
Market Profile: Gel Documentation Systems
- Leading Vendors
- Largest Markets
- Instrument Cost
Industry Watch
- Clinical: LDT Changes Proposed
- Life Sciences: Demand for Lab Space Falls
- Consumer: US Cough Syrup Testing
Region Watch
- China: R&D Spending Rises Double Digits
- Japan: Latest R&D Statistics Released
- Israel: R&D Spending Rises Double Digits
News
- MS, LC/MS & GC/MS
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Spectroscopy
  - Company Announcements
  - Sales & Orders of Note
- Life Sciences Consumables
  - Company Announcements
  - Gene-Based Analysis
  - Company Announcements
  - Product Introductions
  - Cell-Based Analysis
  - Company Announcements
  - Product Introductions
  - Protein-Based Analysis
  - Company Announcements
  - Sales & Orders of Note
- Surface Science
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
Bottom Line

Attachments

IBO 100323 Issue.pdf